Levi Strauss (LEVI) Form 4: Director Acquires DERs, Beneficial Ownership Disclosed
Rhea-AI Filing Summary
Levi Strauss & Co. Form 4: Director Robert Eckert reported acquisitions tied to dividend equivalent rights (DERs) on 08/08/2025. The filing shows an acquisition of 346 DERs relating to Class A Common Stock at $0.00, after which Mr. Eckert is reported to beneficially own 93,815 shares of Class A Common Stock. The filing also reports acquisition of 309 DERs relating to Class B Common Stock (convertible one-for-one into Class A) at $0.00, with 219,098 derivative securities reported as beneficially owned following the transaction.
The explainers state that DERs are contingent rights to receive one share upon settlement and vest consistent with the underlying awards; some underlying awards are fully vested but subject to deferred delivery. The form was signed by an attorney-in-fact on 08/12/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine equity-based compensation vesting increases director holdings; aligns interests but is not a substantive corporate governance change.
The filing documents issuance/settlement of dividend equivalent rights (DERs) to a director rather than an open-market purchase. These DERs vest consistent with underlying awards and some are subject to deferred delivery, which is common in executive/director compensation to align long-term interests. The reported post-transaction holdings—93,815 Class A shares and 219,098 derivative securities—reflect aggregate beneficial ownership reporting, not an external cash transaction. Governance impact is limited and routine.
TL;DR: Transaction codes show acquisitions at $0 via DER settlement; this is a compensation-related issuance, not a market buy/sell event.
The Form 4 records Transaction Code A acquisitions on 08/08/2025 for DERs tied to both Class A and Class B stock, each with a stated price of $0.00. The Class B DERs are noted as convertible one-for-one into Class A shares, which explains the mix of reported holdings. For trading surveillance, these are issuer-granted rights and not market trades, so immediate market-impact or signaling is typically limited. The filing was executed by an attorney-in-fact on 08/12/2025.